What does new study show on diabetes risks? | Explained | Current Affairs | Vision IAS

Daily News Summary

Get concise and efficient summaries of key articles from prominent newspapers. Our daily news digest ensures quick reading and easy understanding, helping you stay informed about important events and developments without spending hours going through full articles. Perfect for focused and timely updates.

News Summary

Sun Mon Tue Wed Thu Fri Sat

    What does new study show on diabetes risks? | Explained

    2 min read

    Non-Communicable Diseases (NCDs) and Diabetes in India

    India faces a significant burden of Non-Communicable Diseases (NCDs), with over 100 million people diagnosed with diabetes and another 136 million being pre-diabetic. Most current diagnostic tools detect diabetes only after considerable damage has occurred.

    New Study on Metabolomic Profiling

    A study by researchers from IIT Bombay, Osmania Medical College, and Clarity Bio Systems, published in the Journal of Proteome Research, suggests that metabolites in the blood could serve as early indicators for diabetes and related complications, especially kidney disease.

    • Metabolites: Small molecules like sugars, amino acids, and lipids produced during metabolic processes. 
    • Metabolomic Profiling: Allows detection of subtle changes in body chemistry, potentially preceding disease symptoms. 
    • Techniques: Utilizes liquid chromatography and mass spectrometry to analyze metabolites from blood samples. 

    Study Methodology and Findings

    The study involved collecting dried blood spots from 52 participants, including healthy individuals, diabetics, and those with diabetic kidney disease (DKD).

    • Identified 26 metabolites significantly different between healthy and diabetic individuals.
    • Detected 7 metabolites that showed progressive increase in individuals with kidney complications.
    • Found two distinct subgroups among diabetics based on their metabolic profiles.

    Implications for Healthcare

    • Early Detection: Metabolomic profiling could identify disease risk before symptoms appear, facilitating early intervention. 
    • Personalized Care: Enables grouping patients by metabolic profiles for tailored interventions. 
    • Challenges: Small sample size, need for larger studies, standardizing protocols, and accessibility of technology. 

    Future Prospects

    Researchers aim to conduct larger cohort studies to validate findings and explore their applicability across various demographics. Successful integration of metabolomics into healthcare could shift focus from reactive treatment to proactive prevention.

    • Tags :
    • Non-Communicable Diseases (NCDs)
    • Diabetes in India
    Subscribe for Premium Features

    Quick Start

    Use our Quick Start guide to learn about everything this platform can do for you.
    Get Started